Independent Portfolio Consultants’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Independent Portfolio Consultants's PFE Position: Q2 2017 in Review
Independent Portfolio Consultants reduced its Pfizer (PFE) stake by 8.1% in Q2 2017, selling an estimated $51.6K and leaving 18,464 shares worth $588K. The position accounts for 0.24% of the portfolio, ranked #135.
Independent Portfolio Consultants first reported a position in PFE in Q2 2013 and has held it in 17 quarters since. The position peaked at $1.9M in Q2 2015. 2,050 funds tracked by Wall St. Rank hold PFE as of Q2 2017.
- Independent Portfolio Consultants held 18,464 shares of Pfizer worth $588K as of Q2 2017.
- Independent Portfolio Consultants sold 1,635 Pfizer shares in Q2 2017, an estimated $51.6K.
- Pfizer made up 0.24% of Independent Portfolio Consultants's portfolio in Q2 2017, its #135 holding.
- Independent Portfolio Consultants first reported a position in Pfizer in Q2 2013 and has held it in 17 quarters since.
- Independent Portfolio Consultants's Pfizer position peaked at $1.9M in Q2 2015.
- 2,050 funds tracked by Wall St. Rank held Pfizer as of Q2 2017.
Based on Independent Portfolio Consultants's 13F filing for Q2 2017, filed 6 Jul 2017.